Sandoz Eyes New Biosimilars Head As Stenico Succeeds Retiring Ballester
Stenico Appointed To President, Sandoz International From 1 March
After more than three decades with Sandoz and its former president Novartis, Francisco Ballester is retiring, with his former International region president role going to Sandoz’s global biosimilars head, Peter Stenico.
